Invesco Pharmaceuticals ETF

Frequently Asked Questions About PJP

What does PJP invest in?

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

What is the expense ratio of PJP?

Invesco Pharmaceuticals ETF (PJP) charges an expense ratio of 0.58%. This is the annual fee deducted from fund assets to cover management and operations.

How big is PJP?

Invesco Pharmaceuticals ETF (PJP) manages $564.2M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is PJP actively managed or an index fund?

PJP's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was PJP launched?

Invesco Pharmaceuticals ETF (PJP) launched in June 2005 and is managed by Invesco.

How has PJP performed?

PJP's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.